IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q4 2021 Holdings

Filed 2022-02-14 | 38 holdings | $6.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Moderna Inc(MRNA)COM60770K107$4.5M17,581,01669.0%
Sana Biotechnology Inc(SANA)COM799566104$530.0K34,239,0188.2%
Rubius Therapeutics IncCOM78116T103$372.7K38,506,5265.8%
Omega Therapeutics IncCOM68217N105$293.5K25,902,2694.5%
Foghorn Therapeutics Inc(FHTX)COM344174107$289.9K12,674,1204.5%
Evelo Biosciences IncCOM299734103$139.8K23,030,0692.2%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$119.8K14,378,8021.9%
Denali Therapeutics Inc(DNLI)COM24823R105$116.9K2,619,9681.8%
Kaleido Biosciences Inc(KLDO)COM483347100$46.8K19,575,7100.7%
Codiak Biosciences Inc(32W)COM192010106$29.0K2,607,3030.4%
Sigilon Therapeutics IncCOM82657L107$28.6K10,370,3690.4%
Axcella Health IncCOM05454B105$26.2K12,548,4140.4%
Syros Pharmaceuticals IncCOM87184Q107$9.6K2,938,4940.1%